Pharmacopsychiatry

Covering all new advances in the field of psychotropic drugs, Pharmacopsychiatry provides psychiatrists, neuroscientists and clinicians with key clinical insights and describes new avenues of research and treatment. The pharmacological and neurobiological bases of psychiatric disorders are discussed by presenting clinical and experimental research.

Pharmacopsychiatry publishes information about controlled clinical trials and meeting proceedings, and serves as a state-of-the-art tool for advancing the field and setting European standards.

Includes sections on:

• Basic/translational/clinical psychopharmacology 
• Biological psychiatry 
• Neuroimaging and neurophysiology 
• Basic and clinical neurosciences
• Biological psychology
• Pharmacogenetics 

Thieme Award 2025 for the Most Innovative Pharmacopsychiatry Original Paper

Thieme awards every year the most promising paper published in Pharmacopsychiatry in the previous year. The decision of the jury – the Editors and Advisory Board of the journal – is strictly based on scientific quality and on the interest that the paper has met with in the scientific community. The prize money is EUR 500.

This year's winners are:

Alberto Parabiaghi, Alessia A. Galbussera, Barbara D’Avanzo, Mauro Tettamanti, Ida Fortino, Angelo Barbato

for their paper

2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation

Click here to read the paper for free.